Pre-Clinical Diastolic Dysfunction in Diabetic Patients. Where Do We Go From Here?

Journal of the American College of Cardiology

Volumn 55, Issue 4, 2010, Pages 306-308

  Greenberg, Barry ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

diabetes; diastolic dysfunction; heart failure

Indexed keywords

CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; EDITORIAL; FOLLOW UP; HEART FAILURE; HUMAN; HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

DIABETES COMPLICATIONS; HEART FAILURE; HEART FAILURE, DIASTOLIC; HUMANS; RISK FACTORS;

EID: 74049102234     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.12.002     Document Type: Editorial

References (15)

1. Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics: 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (errata in Circulation 2007;115:e172). Circulation 115 (2007) e69-e171
2. Kenchaiah S., Narula J., and Vasan R.S. Risk factors for heart failure. Med Clin North Am 88 (2004) 1145-1172
3. From A.M., Scott C.G., and Chen H.H. The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction: a population-based study. J Am Coll Cardiol 55 (2010) 300-305
4. Nakai H., Takeuchi M., Nishikage T., Lang R.M., and Otsuji Y. Subclinical left ventricular dysfunction in asymptomatic diabetic patients assessed by two-dimensional speckle tracking echocardiography: correlation with diabetic duration. Eur J Echocardiogr 10 (2009) 926-932
5. Ng A.C., Delgado V., Bertini M., et al. Findings from left ventricular strain and strain rate imaging in asymptomatic patients with type 2 diabetes mellitus. Am J Cardiol 104 (2009) 1398-1401
6. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. (errata in N Engl J Med 1992;327:1768). N Engl J Med 327 (1992) 685-691
7. Yusuf S., Pfeffer M.A., Swedberg K., et al., CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362 (2003) 777-781
8. Massie B.M., Carson P.E., McMurray J.J., et al., I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359 (2008) 2456-2467
9. Mogelvang R., Goetze J.P., Pedersen S.A., et al. Preclinical systolic and diastolic dysfunction assessed by tissue Doppler imaging is associated with elevated plasma pro-B-type natriuretic peptide concentrations. J Card Fail 15 (2009) 489-495
10. Lubien E., DeMaria A., Krishnaswamy P., et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. (errata in Circulation 2002;106:387). Circulation 105 (2002) 595-601
11. Betti I., Castelli G., Barchielli A., et al. The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study. J Card Fail 15 (2009) 377-384
12. Daniels L., Clopton P., Jiang K., Greenberg B., and Maisel A. Prognosis of stage A or B heart failure patients with elevated B-type natriuretic peptide levels. J Card Fail (2010) In press
13. Martos R., Baugh J., Ledwidge M., et al. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 115 (2007) 888-895
14. ADVANCE Collaborative Group, Patel A., MacMahon S., Chalmers J., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358 (2008) 2560-2572
15. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein H.C., Miller M.E., Byington R.P., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 (2008) 2545-2559